The use of non-invasive and invasive diagnostic methods to evaluate the effectiveness of three artificial tear preparations in the treatment of dry eye syndrome

Main Article Content

Dorota Szczęsna-Iskander
Maria Muzyka-Woźniak
Maciej Osęka

Abstract

Objectives: The assessment of three commercially available artificial tear formulations for dry eye disease (DED) treatment.


Material and methods: This 4-week, randomised prospective study enrolled 30 patients with DED symptoms. Patients received (in scheme 1 : 1 : 1): group 1 – dexpanthenol 2% and hydroxypropylcelulose 0.5%; group 2 – trehalose 3% and sodium hyaluronate 0.15%; group 3 – sodium hyaluronate 0.24%. All assessments were performed before and 28 days after treatment and included Ocular Surface Disease Index (OSDI), subjective symptoms, non-invasive imaging using a cone- and a bowl-type videokeratoscope, Schirmer test and slit lamp exam including fluorescein and lissamine green ocular surface staining. T-test was used for statistical analysis of the results.


Results: All groups had significantly lower OSDI. Four subjective symptoms improved in group 1 and only two subjective symptoms improved in groups 2 and 3. Non-invasive break-up time (NIBUT) was significantly longer after treatment in groups 1 and 3 (p < 0.05). The ratio of tear film surface quality distortion was lower only in group 1 (p < 0.05). Corneal fluorescein staining was reduced in all groups after treatment (p < 0.05). There were no statistically significant changes in Schirmer test, tear meniscus height and NIBUT measured with a bowl-type videokeratoscope after treatment.


Conclusions: All preparations reduced the subjective and objective symptoms of DED. The corneal epithelium and general subjective comfort improved regardless of used artificial tear formulation. Nonetheless, the tear film break-up time change depended on the diagnostic method and treatment type.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Szczęsna-Iskander D, Muzyka-Woźniak M, Osęka M. The use of non-invasive and invasive diagnostic methods to evaluate the effectiveness of three artificial tear preparations in the treatment of dry eye syndrome. Ophthatherapy [Internet]. 2019Jun.30 [cited 2024Mar.28];6(2):95-104. Available from: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/938
Section
Articles

References

1. Craig JP, Nelson JD, Azar DT et al. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017; 15: 802-12.
2. Gulati S, Jain S. Ocular pharmacology of tear film, dry eye, and allergic conjunctivitis. Handb Exp Pharmacol. 2017; 242: 97-118.
3. Nakamura M, Hikida M, Nakano T et al. Characterization of water retentive properties of hyaluronan. Cornea. 1993; 12: 433-6.
4. Gomes JA, Amankwah R, Powell-Richards A et al. Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol. 2004; 88: 821-5.
5. Cejka C, Kubinova S, Cejkova J. Trehalose in ophthalmology. Histol Histopathol. 2019; 34(6): 611-18.
6. Chen W, Zhang X, Liu M et al. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res. 2009; 89: 311-8.
7. Raczyńska K, Iwaszkiewicz-Bilikiewicz B, Stozkowska W et al. Clinical evaluation of provitamin B5 drops and gel for postoperative treatment of corneal and conjuctival injuries. Klin Oczna. 2003; 105: 175-8.
8. Lee R, Yeo S, Tun Aung H et al. A greement of noninvasive tear break-up time measurement between Tomey RT-7000 Auto Refractor-Keratometer and Oculus Keratograph 5M. Clin Ophthalmol. 2016; 10: 1785-90.
9. Best N, Drury L, Wolffsohn JS. Clinical evaluation of the Oculus Keratograph. Contact Lens Anterior Eye. 2012; 35: 171-4.
10. Fuller DG, Potts K, Kim J. Noninvasive tear breakup times and ocular surface disease. Optom Vis Sci. 2013; 90: 1086-91.
11. Schiffman RM, Christianson MD, Jacobsen G et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000; 118: 615-21.
12. Whitcher JP, Shiboski CH, Shiboski SC et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren’s Syndrome International Registry. Am J Ophthalmol. 2010; 149: 405-15.
13. Szczesna-Iskander DH, Alonso-Caneiro D, Iskander DR. Objective Measures of Pre-lens Tear Film Dynamics versus Visual Responses. Optom Vis Sci. 2016; 93: 872-880.
14. Owsley C, Knoblauch K, Katholi C. When does visual aging begin? Invest Ophthalmol Visual Sci. 1992; 33: 1414.
15. Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014; 34: 502-8.
16. Maharana PK, Raghuwanshi S, Chauhan AK et al. Comparison of the Efficacy of Carboxymethylcellulose 0.5%, Hydroxypropylguar Containing Polyethylene Glycol 400/Propylene Glycol, and Hydroxypropyl Methyl Cellulose 0.3% Tear Substitutes in Improving Ocular Surface Disease Index in Cases of Dry Eye. Middle East Afr J Ophthalmol. 2017; 24: 202-6.
17. Safarzadeh M, Azizzadeh P, Akbarshahi P. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops. J Optom. 2017; 10: 258-64.
18. Moshirfar M, Pierson K, Hanamaikai K et al. Artificial tears potpourri: a literature review. Clin Ophthalmol. 2014; 8: 1419-33.
19. Proksch E, de Bony R, Trapp S et al. Topical use of dexpanthenol: a 70th anniversary article. J Derm Treat. 2017; 28: 1-8.
20. Matsuo T. Trehalose protects corneal epithelial cells from death by drying. Br J Ophthalmol. 2001; 85: 610-2.
21. Aragona P, Colosi P, Rania L et al. Protective Effects of Trehalose on the Corneal Epithelial Cells. ScientificWorldJournal. 2014: 717835.
22. Li J, Roubeix C, Wang Y et al. Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system. Mol Vis. 2012; 18: 317-29.
23. Čejková J, Ardan T, Čejka C et al. Favorable effects of trehalose on the development of UVB-mediated antioxidant/pro-oxidant imbalance in the corneal epithelium, proinflammatory cytokine and matrix metalloproteinase induction, and heat shock protein 70 expression. Graefes Arch Clin Exp Ophthalmol. 2011; 249: 1185-94.
24. Salzillo R, Schiraldi C, Corsuto L et al. Optimization of hyaluronan-based eye drop formulations. Carbohydrate Polymers. 2016; 153: 275-83.
25. Weigel PH, Baggenstoss BA. What is special about 200 kDa hyaluronan that activates hyaluronan receptor signaling? Glycobiology. 2017; 27: 868-77.
26. Oh T, Jung Y, Chang D et al. Changes in the tear film and ocular surface after cataract surgery. Jpn J Ophthalmol. 2012; 56: 113-8.
27. Kohli P, Arya SK, Raj A et al. Changes in ocular surface status after phacoemulsification in patients with senile cataract. Int Ophthalmol. 2018; 39: 1-9.
28. Sullivan BD, Whitmer D, Nichols KK et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2010; 47: 4309-15.
29. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurementsof dry eye. Cornea. 2004; 23: 272-85.
30. Wolffsohn JS, Arita R, Chalmers R et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017; 15: 539-74.
31. Li N, Deng XG, He MF. Comparison of the Schirmer 1 test with and without topical anesthesia for diagnosing dry eye. Int J Opthalmol. 2012; 5: 478-81.
32. Downie LE. Automated tear film surface quality breakup time as a novel clinical marker for tear hyperosmolarity in dry eye disease. Invest Ophthalmol Vis Sci. 2015; 56: 7260-8.
33. Lan W, Lin L, Yang X et al. Automatic noninvasive tear breakup time (TBUT) and conventional fluorescent TBUT. Optom Vis Sci. 2014; 91: 1412-8.
34. Llorens-Quintana C, Szczesna-Iskander DH, Iskander DR. Unified approach to tear film surface analysis with high-speed videokeratoscopy. J Opt Soc Am A. 2019; 36: B15-22.
35. Wang M, Murthy PJ, Blades KJ et al. Comparison of non-invasive tear film stability measurement techniques. Clin Exp Optom. 2017; 101: 13-7.
36. Szczesna-Iskander DH. Post-blink tear film dynamics in healthy and dry eyes during spontaneous blinking. Ocular Surf. 2018; 16: 93-100.
37. Yokoi N, Georgiev GA. Tear film-oriented diagnosis and tear film-oriented therapy for dry eye based on tear film dynamics. Invest Ophthalmol Vis Sci. 2018; 59: DES13–2.
38. Abdelfattah NS, Dastiridou A, Sadda SV et al. Noninvasive imaging of tear film dynamics in eyes with ocular surface disease. Cornea. 2015; 34(10): S48-52.